Association of: 1. WBA with decrease of Aβ1-42 in preclinical AD plus correlation of t-tau and p-tau181 with further atrophy caused by disease progression 2. Hippocampal volume with CSF t-tau and p-tau. Here, MAPT is linked to Alzheimer disease.